Latest filing published 20 Jun 2025 for ORACLE CORP, €1.5M.
George H. Conrades appears as Director in 31 filings published from June 2, 2016 to June 20, 2025. Oracle Corp accounts for 28, ahead of Korsana Biosciences, Inc. (2) and Akamai Technologies Inc (1).
The record is shaped by option exercises: 20, against 8 open-market sales, 2 share grants and one filing of another kind. The sales add up to EUR 11,453,885, with a median of EUR 1,680,853. The three largest: EUR 2,707,861 on May 1, 2024, EUR 2,272,023 on September 22, 2017 and EUR 2,161,544 on May 3, 2024. No purchase is on record.
The year 2017 has the most filings (8), 2024 has 5 and 2016 only one. None falls in the last twelve months, and they are published a median of 2 days after the trade.
At Oracle, 3 of Conrades's trades fall within 30 days of trades by Dorian Daley, Hector Garcia-Molina and Jeffrey Berg, always in the same direction; Michael J. Boskin shares 2.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations